Identifying Protein Targets in Prostate Cancer
Author Information
Author(s): Ummanni Ramesh, Mundt Frederike, Pospisil Heike, Venz Simone, Scharf Christian, Barett Christine, Fälth Maria, Köllermann Jens, Walther Reinhard, Schlomm Thorsten, Sauter Guido, Bokemeyer Carsten, Sültmann Holger, Schuppert A., Brümmendorf Tim H., Balabanov Stefan
Primary Institution: University Hospital Eppendorf, Hamburg, Germany
Hypothesis
The study aims to identify clinically relevant protein targets in prostate cancer using advanced proteomic techniques.
Conclusion
The study identified 79 differentially expressed proteins in prostate cancer compared to benign tissue, suggesting potential biomarkers for diagnosis and treatment.
Supporting Evidence
- The study identified 118 protein spots differentially expressed in cancer compared to benign tissue.
- 79 different proteins were identified through mass spectrometry.
- Principal component analysis clearly separated tumor and normal tissue based on protein expression patterns.
- The study revealed potential diagnostic and prognostic markers for prostate cancer.
Takeaway
Researchers looked at prostate cancer tissues to find proteins that could help doctors tell if someone has cancer, and they found many that could be important.
Methodology
The study used 2D-DIGE and mass spectrometry to analyze protein expression in prostate cancer and benign tissues.
Potential Biases
Potential bias due to the selection of patients and the manual dissection method used.
Limitations
The study focused on a limited number of patients and may not represent all prostate cancer cases.
Participant Demographics
Patients were selected based on elevated PSA levels and definitive pathological examination.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website